We are live on
!
Find out more
SC
Scholtz & Company Portfolio holdings
AUM
$195M
1-Year Est. Return
12.04%
This Fund
S&P 500
This Quarter
Est. Return
+5.09%
1 Year Est. Return
+12.04%
3 Year Est. Return
+82.55%
5 Year Est. Return
+94.25%
10 Year Est. Return
+790.35%
AUM
$235M
AUM Growth
+$8.28M
(+3.7%)
Cap. Flow
-$1.46M
Cap. Flow
% of AUM
-0.62%
Top 10 Holdings %
Top 10 Hldgs %
55.29%
Holding
56
New
6
Increased
14
Reduced
27
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$3.57M |
| 2 |
Advanced Micro Devices
AMD
|
+$3.27M |
| 3 |
Insulet
PODD
|
+$1.65M |
| 4 |
Vericel Corp
VCEL
|
+$1.39M |
| 5 |
Eli Lilly
LLY
|
+$1.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$7.06M |
| 2 |
RCI Hospitality Holdings
RICK
|
+$3.37M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.92M |
| 4 |
ServiceNow
NOW
|
+$2.37M |
| 5 |
NVIDIA
NVDA
|
+$1.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.12% |
| 2 | Healthcare | 16.32% |
| 3 | Consumer Discretionary | 13.62% |
| 4 | Financials | 13.36% |
| 5 | Industrials | 10.71% |
Similar funds
HAS
MHFA
TF
RAM
ICMARC
CPRPA
WAL
CPI
Scholtz & Company's Q2 2024 Portfolio in Review
As of Q2 2024, Scholtz & Company held 56 positions worth $235M, up 3.7% from $227M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Scholtz & Company's Q2 2024 filing shows 6 new, 14 increased, 27 reduced and 6 closed positions. Its largest new stake was Insulet: 9,151 shares worth $1.85M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $7.06M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Scholtz & Company's largest Q2 2024 buy was Insulet: 9,151 shares worth $1.85M.
- Scholtz & Company added most to Abbott in Q2 2024, an estimated $3.57M increase.
- Scholtz & Company's biggest Q2 2024 reduction was RCI Hospitality Holdings, cutting an estimated $3.37M.
- Scholtz & Company fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $7.06M.
- Scholtz & Company's ten largest holdings make up 55% of its $235M portfolio in Q2 2024.
- Scholtz & Company opened 6 new positions and closed 6 in Q2 2024.
- Scholtz & Company's portfolio value rose 3.7% quarter-over-quarter to $235M.
Based on Scholtz & Company's 13F filing for Q2 2024, filed 8 Aug 2024.